Strategic Equity Recent minority stake by Eurazeo signals potential for strategic partnerships and increased backing for global expansion, presenting an opportunity to align with a more investment-backed growth trajectory in ophthalmic instrumentation.

Global Footprint Established presence in France with offices in the US, China, and Japan provides multi-regional access for sales outreach, enabling tailored approaches to major ophthalmology markets and eye banks.

Leading Niche Worldwide leadership in microkeratomes and corneal surgery instruments positions Moria as a premium supplier; target for high-value procurement cycles and potential expandability into adjacent ophthalmic devices.

Revenue Range Current revenue in the low-to-mid single digits with a lean employee base suggests room for larger, scalable deals, multi-year contracts, and opportunities to upsell training, service, and disposables.

Technology Fit Tech stack and global distribution via WordPress, Dynamics, and digital channels indicate openness to modern sales enablement, CRM-driven account targeting, and digital marketing partnerships to accelerate conversions.